Jan 26, 2021
| Chairs: | Barry Buckland (BiologicB, USA) |
|---|---|
| Keshavarz-Moore (UCL, UK) |
The articles for these proceedings are not peer-reviewed.
Please click on the title to view the presentation on your web browser. Please click on the File icon next to the title to download the presentation.
Chairs Introduction, Barry Buckland and Eli Keshavarz-Moore (Video)
Microbial technology supporting COVID-19 vaccine development, John Liddell (Video)
Learnings from the development of a COVID-19 RNA vaccine (Speaker Introduction), Kathrin Jansen (Video)
Development of COVID-19 vaccine based on receptor binding domain from spike protein of SARS-CoV-2, Vikram Paradkar (Video)
C1- A a low cost production platform to combat COVID-19 pandemic, Ronen Tchelet (Video)
Leveraging a plasmid DNA platform for COVID-19 vaccine development, Robert Juba Jr. (Video)
Scaling cell free synthesis of mRNA to enable global herd immunity through COVID-19, Marta Ortega-Valle (Video)
From worms to the small intestinal axis – a new approach to resolving systemic inflammation caused by COVID-19, Mark Bodmer (Video)